These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 6597341

  • 1. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK, Sundstrom C, Yu AL, Levine A.
    Nat Immun Cell Growth Regul; ; 3(4):165-80. PubMed ID: 6597341
    [Abstract] [Full Text] [Related]

  • 2. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 3. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T, Gomez GA, Minowada J.
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [Abstract] [Full Text] [Related]

  • 4. Decreased natural killer cell activity in children with untreated acute leukemia.
    Nasrallah AG, Miale TD.
    Cancer Res; 1983 Nov; 43(11):5580-5. PubMed ID: 6352019
    [Abstract] [Full Text] [Related]

  • 5. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A, Ferm MT, Ng J, Reynolds CW, Ortaldo JR.
    J Immunol; 1988 Jun 15; 140(12):4397-402. PubMed ID: 3131433
    [Abstract] [Full Text] [Related]

  • 6. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.
    Inada M, Okawa H, Suzuki M, Yata J.
    Jpn J Clin Oncol; 1984 Sep 15; 14(3):335-45. PubMed ID: 6592376
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells.
    Pattengale PK, Gidlund M, Nilsson K, Sundström C, Sällström J, Simonsson B, Wigzell H.
    Int J Cancer; 1982 Jan 15; 29(1):1-7. PubMed ID: 6174459
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C, Loher F, Zang C, Ismair MG, Petrides PE.
    Clin Cancer Res; 1999 May 15; 5(5):1115-24. PubMed ID: 10353746
    [Abstract] [Full Text] [Related]

  • 15. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 15; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 16. Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro.
    Sondel PM, O'Brien C, Porter L, Schlossman SF, Chess L.
    J Immunol; 1976 Dec 15; 117(6):2197-203. PubMed ID: 1069027
    [Abstract] [Full Text] [Related]

  • 17. The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen.
    Ziegler-Heitbrock HW, Fütterer A, Rumpold H, Kraft D, Munker R, Riethmüller G.
    Clin Exp Immunol; 1984 Nov 15; 58(2):470-7. PubMed ID: 6333947
    [Abstract] [Full Text] [Related]

  • 18. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
    Dermime S, Mavroudis D, Jiang YZ, Hensel N, Molldrem J, Barrett AJ.
    Bone Marrow Transplant; 1997 May 15; 19(10):989-99. PubMed ID: 9169643
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chronic myelocytic leukemia terminating in blast cell crisis with lymphoblastic characteristics.
    Walters TR, Minowada J, Tsubota T, Kataoka K, Han T.
    Pediatrics; 1978 Nov 15; 62(5):795-800. PubMed ID: 281667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.